China-based biopharmaceutical company Zai Lab Ltd, which focuses on developing medicines for cancer, autoimmune and infectious diseases, appointed Kai-Xian Chen to its board.

Chen replaces Marietta Wu on the board. He has over 55 years of academic and administrative experience and has also served as a member of the National Committee of Chinese People's Political Consultative Conference from 2007 to 2017.